South Platte Sentinel | Sterling FDA approval for treatment marks 'pivotal moment in ALS research' Eastern Plains • Apr 27, 2023
Sentinel Colorado | Aurora Alzheimer's drug shows promise in early results of study Denver Area • Sep 28, 2022
Grand Junction Sentinel Biogen Cuts Price of Controversial Aduhelm in Half Northwest Colorado • Dec 21, 2021
Grand Junction Sentinel Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC Northwest Colorado • Jul 26, 2021
Sentinel Colorado | Aurora FDA trims use of contentious Alzheimer's drug amid backlash Denver Area • Jul 9, 2021
Sentinel Colorado | Aurora Medicare copays for new Alzheimer's drug could reach $11,500 Denver Area • Jun 10, 2021
Sentinel Colorado | Aurora EXPLAINER: How will insurers cover a new Alzheimer's drug? Denver Area • Jun 8, 2021
9NEWS Denver | Video First new Alzheimer's treatment in more than 2 decades could be approved Monday (Video) Denver Area • Jun 7, 2021
The Fence Post | Greeley Biogenic CO2 Coalition urges Congress to monitor EPA rule Front Range • May 12, 2020
Sentinel Colorado | Aurora Cluster of coronavirus cases is tied to US biotech meeting Denver Area • Mar 12, 2020
Sentinel Colorado | Aurora Biogen reanalyzes studies, presses ahead on Alzheimer's drug Denver Area • Oct 23, 2019